The GLP-1 RA monitoring report describes more detailed information about the overall population of patients being prescribed these medications (including demographics, comorbidities, social drivers of health data like income and education, and more), and the proportion and characteristics of patients who actually filled a GLP-1 RA prescription over time using dispenses
Immunocomplexes were visualized by using Clarity Max Western ECL Substrate (Bio-Rad Laboratories cat#1705062) Immunocomplexes were observed through ChemiDOC Imaging System with Image LAB Software (Bio-Rad Laboratories, Version 6.1)
It's one of the most common questions we hear in clinic, usually asked quietly, near the end of a visit
Plan close follow-up with your care team, such as your primary care physician, endocrinologist and ophthalmologist, in the first 12 to 18 months of taking a GLP-1 agonist, especially if your A1C is likely to drop quickly
Instead, follow-up timing for patients on GLP-1 therapy is becoming more personalized and dynamic
